| | | | | | | | | | | | | | | | | | | | | |
<?xml version="1.0" encoding="windows-1252"?> |
<!-- XBRL Document Created with Wdesk from Workiva --> |
<!-- --> |
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/ConcentrationOfCreditRiskDetails" xlink:href="esmc-20190930.xsd#ConcentrationOfCreditRiskDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/ConcentrationOfCreditRiskNotes" xlink:href="esmc-20190930.xsd#ConcentrationOfCreditRiskNotes" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/ConcentrationOfCreditRiskTables" xlink:href="esmc-20190930.xsd#ConcentrationOfCreditRiskTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/ConsolidatedBalanceSheets" xlink:href="esmc-20190930.xsd#ConsolidatedBalanceSheets" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="esmc-20190930.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="esmc-20190930.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/ConsolidatedStatementsOfOperations" xlink:href="esmc-20190930.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/ConsolidatedStatementsOfShareholdersEquityAndComprehensiveLoss" xlink:href="esmc-20190930.xsd#ConsolidatedStatementsOfShareholdersEquityAndComprehensiveLoss" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/DiscontinuedOperationDetails" xlink:href="esmc-20190930.xsd#DiscontinuedOperationDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/DiscontinuedOperationNotes" xlink:href="esmc-20190930.xsd#DiscontinuedOperationNotes" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/DiscontinuedOperationTables" xlink:href="esmc-20190930.xsd#DiscontinuedOperationTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/DocumentAndEntityInformation" xlink:href="esmc-20190930.xsd#DocumentAndEntityInformation" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/GoingConcernDetails" xlink:href="esmc-20190930.xsd#GoingConcernDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/GoingConcernNotes" xlink:href="esmc-20190930.xsd#GoingConcernNotes" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/GoingConcernTables" xlink:href="esmc-20190930.xsd#GoingConcernTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/InventoriesDetails" xlink:href="esmc-20190930.xsd#InventoriesDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/InventoriesNotes" xlink:href="esmc-20190930.xsd#InventoriesNotes" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/InventoriesTables" xlink:href="esmc-20190930.xsd#InventoriesTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/LeasesDetails" xlink:href="esmc-20190930.xsd#LeasesDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/LeasesNotes" xlink:href="esmc-20190930.xsd#LeasesNotes" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/LeasesPolicies" xlink:href="esmc-20190930.xsd#LeasesPolicies" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/LeasesTables" xlink:href="esmc-20190930.xsd#LeasesTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/LineOfCreditDetails" xlink:href="esmc-20190930.xsd#LineOfCreditDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/LineOfCreditNotes" xlink:href="esmc-20190930.xsd#LineOfCreditNotes" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/OrganizationAndDescriptionOfBusiness" xlink:href="esmc-20190930.xsd#OrganizationAndDescriptionOfBusiness" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/OrganizationAndDescriptionOfBusinessDetails" xlink:href="esmc-20190930.xsd#OrganizationAndDescriptionOfBusinessDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/RelatedPartyTransactions" xlink:href="esmc-20190930.xsd#RelatedPartyTransactions" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/RelatedPartyTransactionsDetails" xlink:href="esmc-20190930.xsd#RelatedPartyTransactionsDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/RetirementAndPostRetirementPlansDetails" xlink:href="esmc-20190930.xsd#RetirementAndPostRetirementPlansDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/RetirementAndPostRetirementPlansNotes" xlink:href="esmc-20190930.xsd#RetirementAndPostRetirementPlansNotes" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/RetirementAndPostRetirementPlansTables" xlink:href="esmc-20190930.xsd#RetirementAndPostRetirementPlansTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/RevenueFromContractsWithCustomersDetails" xlink:href="esmc-20190930.xsd#RevenueFromContractsWithCustomersDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/RevenueFromContractsWithCustomersNotes" xlink:href="esmc-20190930.xsd#RevenueFromContractsWithCustomersNotes" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/RevenueFromContractsWithCustomersPolicies" xlink:href="esmc-20190930.xsd#RevenueFromContractsWithCustomersPolicies" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/RevenueFromContractsWithCustomersTables" xlink:href="esmc-20190930.xsd#RevenueFromContractsWithCustomersTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/SignificantAccountingPolicies" xlink:href="esmc-20190930.xsd#SignificantAccountingPolicies" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:href="esmc-20190930.xsd#SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/SignificantAccountingPoliciesCashAndCashEquivalentsDetails" xlink:href="esmc-20190930.xsd#SignificantAccountingPoliciesCashAndCashEquivalentsDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/SignificantAccountingPoliciesDeferredRevenueDetails" xlink:href="esmc-20190930.xsd#SignificantAccountingPoliciesDeferredRevenueDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/SignificantAccountingPoliciesEarningPerShareDetailsDetails" xlink:href="esmc-20190930.xsd#SignificantAccountingPoliciesEarningPerShareDetailsDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/SignificantAccountingPoliciesGoodwillAndIntangibleAssetsDetails" xlink:href="esmc-20190930.xsd#SignificantAccountingPoliciesGoodwillAndIntangibleAssetsDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/SignificantAccountingPoliciesIncomeTaxDetails" xlink:href="esmc-20190930.xsd#SignificantAccountingPoliciesIncomeTaxDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/SignificantAccountingPoliciesInventoryDetails" xlink:href="esmc-20190930.xsd#SignificantAccountingPoliciesInventoryDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails" xlink:href="esmc-20190930.xsd#SignificantAccountingPoliciesNetIncomeLossPerShareDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/SignificantAccountingPoliciesPolicies" xlink:href="esmc-20190930.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple"/> |
| <link:roleRef roleURI="http://www.escalonmed.com/role/SignificantAccountingPoliciesTables" xlink:href="esmc-20190930.xsd#SignificantAccountingPoliciesTables" xlink:type="simple"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/ConcentrationOfCreditRiskDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/ConcentrationOfCreditRiskNotes" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/ConcentrationOfCreditRiskTables" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/ConsolidatedBalanceSheets" xlink:type="extended"> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:type="locator"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:type="locator"/> |
| | <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32f41ea9-05c6-e713-464b-586a571d1c1f" xlink:type="locator"/> |
| | <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32f41ea9-05c6-e713-464b-586a571d1c1f" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaap_RestrictedCashCurrent_81b308b1-c4ff-480c-3942-2317dfd5262a" xlink:type="locator"/> |
| | <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_RestrictedCashCurrent_81b308b1-c4ff-480c-3942-2317dfd5262a" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_928a1618-af56-709a-989c-a303706b8ca2" xlink:type="locator"/> |
| | <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_928a1618-af56-709a-989c-a303706b8ca2" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:type="locator"/> |
| | <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaap_OtherAssetsCurrent_79aabdc0-b963-1fd1-4e81-8c0801b1ebca" xlink:type="locator"/> |
| | <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_OtherAssetsCurrent_79aabdc0-b963-1fd1-4e81-8c0801b1ebca" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:type="locator"/> |
| | <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_52f5671e-53e6-6055-795e-6bd414fd86c2" xlink:type="locator"/> |
| | <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_52f5671e-53e6-6055-795e-6bd414fd86c2" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_99bd5160-e32a-dcfc-e4fd-38dda5d465b0" xlink:type="locator"/> |
| | <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_99bd5160-e32a-dcfc-e4fd-38dda5d465b0" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:type="locator"/> |
| | <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_61ff83b4-33a0-68aa-a4ad-7dbd9b595dbf" xlink:type="locator"/> |
| | <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_61ff83b4-33a0-68aa-a4ad-7dbd9b595dbf" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:type="locator"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:type="locator"/> |
| | <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:to="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:type="locator"/> |
| | <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaap_ShortTermBorrowings_422d7c41-753d-7765-5880-50978d071d31" xlink:type="locator"/> |
| | <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_ShortTermBorrowings_422d7c41-753d-7765-5880-50978d071d31" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNotesPayableCurrent" xlink:label="loc_us-gaap_OtherNotesPayableCurrent_911723a5-cfea-232b-5b06-0c21e7791663" xlink:type="locator"/> |
| | <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_OtherNotesPayableCurrent_911723a5-cfea-232b-5b06-0c21e7791663" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_c2c48170-d0ff-2c37-effc-ff5f53e30dcb" xlink:type="locator"/> |
| | <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_AccountsPayableCurrent_c2c48170-d0ff-2c37-effc-ff5f53e30dcb" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:type="locator"/> |
| | <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaap_InterestPayableCurrent_84c97d53-d75c-0fec-d05e-498cb2460450" xlink:type="locator"/> |
| | <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_InterestPayableCurrent_84c97d53-d75c-0fec-d05e-498cb2460450" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_ce0a2b9f-7d6d-5f26-0a1b-2f0b2915c2e1" xlink:type="locator"/> |
| | <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_ce0a2b9f-7d6d-5f26-0a1b-2f0b2915c2e1" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_09c9f846-159b-1776-fceb-d1cad0eb94ab" xlink:type="locator"/> |
| | <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_09c9f846-159b-1776-fceb-d1cad0eb94ab" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_56ae2fbe-1d9b-2820-d3f0-88126fbd28ba" xlink:type="locator"/> |
| | <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_DeferredRevenueCurrent_56ae2fbe-1d9b-2820-d3f0-88126fbd28ba" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_008489b9-d348-7423-9850-c3ac37bce631" xlink:type="locator"/> |
| | <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_008489b9-d348-7423-9850-c3ac37bce631" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_f7f6a3c1-4b60-6e47-4dbc-badebe1fbd2c" xlink:type="locator"/> |
| | <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_f7f6a3c1-4b60-6e47-4dbc-badebe1fbd2c" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:type="locator"/> |
| | <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:to="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_ea289a9d-deba-2cde-21e4-3d0ae7a1f011" xlink:type="locator"/> |
| | <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_PreferredStockValue_ea289a9d-deba-2cde-21e4-3d0ae7a1f011" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_aefe3f0c-abe4-5b83-9a64-da77d8e253dd" xlink:type="locator"/> |
| | <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_CommonStockValue_aefe3f0c-abe4-5b83-9a64-da77d8e253dd" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_6dca832a-861c-478d-b1a0-396533beb40d" xlink:type="locator"/> |
| | <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_AdditionalPaidInCapital_6dca832a-861c-478d-b1a0-396533beb40d" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a59bc5ae-63a0-c9bc-32f7-e2bd9f32bd26" xlink:type="locator"/> |
| | <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a59bc5ae-63a0-c9bc-32f7-e2bd9f32bd26" xlink:type="arc"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended"> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:type="locator"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:type="locator"/> |
| | <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:type="locator"/> |
| | <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:type="locator"/> |
| | <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:type="locator"/> |
| | <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="locator"/> |
| | <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b11c1cb0-596b-4c3d-0283-76cef67837c7" xlink:type="locator"/> |
| | <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b11c1cb0-596b-4c3d-0283-76cef67837c7" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_c14a9ac3-04f1-504d-4cf1-cf62b3c1adf2" xlink:type="locator"/> |
| | <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_c14a9ac3-04f1-504d-4cf1-cf62b3c1adf2" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_41e96f8d-e499-8de8-69a8-27f1c7d4df6e" xlink:type="locator"/> |
| | <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_41e96f8d-e499-8de8-69a8-27f1c7d4df6e" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f96c19e-85fe-99f6-cec0-c2c9d7470ed4" xlink:type="locator"/> |
| | <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f96c19e-85fe-99f6-cec0-c2c9d7470ed4" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_334f1d33-7cae-7fd2-9d83-bb387fc2f3dd" xlink:type="locator"/> |
| | <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_334f1d33-7cae-7fd2-9d83-bb387fc2f3dd" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d54a644c-3d3c-bcc1-da30-2f136651f90f" xlink:type="locator"/> |
| | <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d54a644c-3d3c-bcc1-da30-2f136651f90f" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0a39d2ee-656d-ead5-a676-41794b4da8f4" xlink:type="locator"/> |
| | <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_0a39d2ee-656d-ead5-a676-41794b4da8f4" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2d76eef5-dce5-0152-632e-9bab39da698c" xlink:type="locator"/> |
| | <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_2d76eef5-dce5-0152-632e-9bab39da698c" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:label="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_d76ae7cc-4d55-88fb-2f29-71f1f1aa74f3" xlink:type="locator"/> |
| | <link:calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_d76ae7cc-4d55-88fb-2f29-71f1f1aa74f3" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForLeasingCosts" xlink:label="loc_us-gaap_PaymentsForLeasingCosts_867ddb19-4645-508e-59ba-7132c5d31514" xlink:type="locator"/> |
| | <link:calculationArc order="11" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_PaymentsForLeasingCosts_867ddb19-4645-508e-59ba-7132c5d31514" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_f37803fe-8fc6-3fc4-e497-674e18f03ea5" xlink:type="locator"/> |
| | <link:calculationArc order="12" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_f37803fe-8fc6-3fc4-e497-674e18f03ea5" xlink:type="arc"/> |
| | <link:loc xlink:href="esmc-20190930.xsd#esmc_Increasedecreaseinliabilitiesofdiscontinuedoperations" xlink:label="loc_esmc_Increasedecreaseinliabilitiesofdiscontinuedoperations_7769d5da-ac6b-5230-460c-21ebf97f4bc4" xlink:type="locator"/> |
| | <link:calculationArc order="13" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_esmc_Increasedecreaseinliabilitiesofdiscontinuedoperations_7769d5da-ac6b-5230-460c-21ebf97f4bc4" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_72092153-6d23-6ed2-386d-5561faf5c226" xlink:type="locator"/> |
| | <link:calculationArc order="14" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_72092153-6d23-6ed2-386d-5561faf5c226" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_8b5c4371-c0a9-6562-81fc-36e3ee510d15" xlink:type="locator"/> |
| | <link:calculationArc order="15" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_8b5c4371-c0a9-6562-81fc-36e3ee510d15" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_eff09578-f037-1eb7-c0f0-39ba77f668a1" xlink:type="locator"/> |
| | <link:calculationArc order="16" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_fd33978d-50b8-db74-6695-8c6dbaac3547" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_eff09578-f037-1eb7-c0f0-39ba77f668a1" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_11e67a5b-b991-9b9e-ce71-4134920b3689" xlink:type="locator"/> |
| | <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9743d583-dfae-6ae9-f133-a1e331df792c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations_11e67a5b-b991-9b9e-ce71-4134920b3689" xlink:type="arc"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended"> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:type="locator"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4562fc03-cbaf-a89b-d454-b9d16c5936b8" xlink:type="locator"/> |
| | <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4562fc03-cbaf-a89b-d454-b9d16c5936b8" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:type="locator"/> |
| | <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1c65a201-fd8e-32d7-dad9-c6d1d5719594" xlink:type="locator"/> |
| | <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1c65a201-fd8e-32d7-dad9-c6d1d5719594" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_693c47dd-e6fa-9c85-6a65-7baa26f76b5e" xlink:type="locator"/> |
| | <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_693c47dd-e6fa-9c85-6a65-7baa26f76b5e" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_11c9d7e5-c56e-e78a-ae7b-17989a817204" xlink:type="locator"/> |
| | <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_8823ccfd-55af-348e-39a2-91433072d2c9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_11c9d7e5-c56e-e78a-ae7b-17989a817204" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c5398800-6e68-ed86-a47c-16106e0730c2" xlink:type="locator"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_41e96f8d-e499-8de8-69a8-27f1c7d4df6e" xlink:type="locator"/> |
| | <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c5398800-6e68-ed86-a47c-16106e0730c2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_41e96f8d-e499-8de8-69a8-27f1c7d4df6e" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_5fcda05e-5b0d-7f20-111d-115dec47eebc" xlink:type="locator"/> |
| | <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c5398800-6e68-ed86-a47c-16106e0730c2" xlink:to="loc_us-gaap_InvestmentIncomeInterest_5fcda05e-5b0d-7f20-111d-115dec47eebc" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_a56b34b7-57ab-a07c-7f03-8366849a14f0" xlink:type="locator"/> |
| | <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c5398800-6e68-ed86-a47c-16106e0730c2" xlink:to="loc_us-gaap_InterestExpense_a56b34b7-57ab-a07c-7f03-8366849a14f0" xlink:type="arc"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/ConsolidatedStatementsOfShareholdersEquityAndComprehensiveLoss" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/DiscontinuedOperationDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/DiscontinuedOperationNotes" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/DiscontinuedOperationTables" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/DocumentAndEntityInformation" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/GoingConcernDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/GoingConcernNotes" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/GoingConcernTables" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/InventoriesDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/InventoriesNotes" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/InventoriesTables" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/LeasesDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/LeasesNotes" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/LeasesPolicies" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/LeasesTables" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/LineOfCreditDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/LineOfCreditNotes" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/OrganizationAndDescriptionOfBusiness" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/OrganizationAndDescriptionOfBusinessDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/RelatedPartyTransactions" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/RelatedPartyTransactionsDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/RetirementAndPostRetirementPlansDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/RetirementAndPostRetirementPlansNotes" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/RetirementAndPostRetirementPlansTables" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/RevenueFromContractsWithCustomersDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/RevenueFromContractsWithCustomersNotes" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/RevenueFromContractsWithCustomersPolicies" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/RevenueFromContractsWithCustomersTables" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/SignificantAccountingPolicies" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/SignificantAccountingPoliciesCashAndCashEquivalentsDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/SignificantAccountingPoliciesDeferredRevenueDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/SignificantAccountingPoliciesEarningPerShareDetailsDetails" xlink:type="extended"> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21ce4f2f-397c-6c02-8635-7c94146a06a0" xlink:type="locator"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2dd9a981-e559-d141-f1c2-4db79f71a7ef" xlink:type="locator"/> |
| | <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21ce4f2f-397c-6c02-8635-7c94146a06a0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2dd9a981-e559-d141-f1c2-4db79f71a7ef" xlink:type="arc"/> |
| | <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_e3291fb3-b8d8-4cd8-31f2-be55dee6fa8e" xlink:type="locator"/> |
| | <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21ce4f2f-397c-6c02-8635-7c94146a06a0" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_e3291fb3-b8d8-4cd8-31f2-be55dee6fa8e" xlink:type="arc"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/SignificantAccountingPoliciesGoodwillAndIntangibleAssetsDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/SignificantAccountingPoliciesIncomeTaxDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/SignificantAccountingPoliciesInventoryDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/SignificantAccountingPoliciesNetIncomeLossPerShareDetails" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended"/> |
| <link:calculationLink xlink:role="http://www.escalonmed.com/role/SignificantAccountingPoliciesTables" xlink:type="extended"/> |
| </link:linkbase> |